Skip to content

Celeste+ 8

by Ensodata, Inc.

Celeste+ 8 is a Class II device made by Ensodata, Inc., cleared under FDA 510(k) K173974 on 14 Jul 2019 and listed in FDA GUDID since 7 Apr 2025 (UDI-DI 00864458000452), active as of 22 Oct 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

510(k) K173974

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00864458000452 UDI-DI Date7 Apr 2025ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK173974 Date14 Jul 2019DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K173974 decided 14 Jul 2019 Active
  • FDA GUDID UDI-DI 00864458000452 listed 7 Apr 2025 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K173974
  2. Listed FDA GUDID 00864458000452

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Celeste+
Generic name
Sleep disorder interpretive software, professional-only
Model / reference
8
Primary DI / UDI-DI
00864458000452
510(k) Number
FDA product code
MNR
GMDN term
Sleep disorder interpretive software, professional-only
Device class
Class II
Regulation number
868.2375
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code MNR (Ventilatory Effort Recorder).

Other devices from Ensodata, Inc.

  • EnsoSleep 8

    Class II
  • EnsoSleep PPG 8

    Class II
  • EnsoSleep

    Class II
  • Aurora

    Class II

See all devices from Ensodata, Inc. →

Properties

  • Prescription use
  • Lot / batch number
  • Manufacturing date
Other properties (12, all answered No)